JUNE 17-19, 2024

Medical Innovation Challenge


Medical Threat Reduction Challenge and $50K Prize

Enter your innovation for a chance to pitch and win funding from a $50,000 award at TechConnect World, furnished by Advanced Technology International (ATI) and the Medical CBRN Defense Consortium (MCDC). Up to 25 finalists will pitch on-stage before a panel of judges to include federal funders, consortium managers, investors, and private corporations as well as a broader audience of attendees from the conference.


Areas of Interest:

  • PREVENTION: Vaccine manufacturing platforms, needle free delivery platforms, mRNA vaccines for biological threat agent diseases, vaccine encapsulation technologies, vaccine capability areas, accelerated antibodies prototype development, etc.

  • TREATMENT: Reactivating and consolidated nerve agent treatment systems, small molecule therapeutics, therapeutics capability areas, gene-encoded MCM development and response platforms, etc.

  • DIAGNOSTICS: CBRN medical decision systems and agent identification, opioid exposure diagnosis, microphysiological systems, advanced diagnostic capabilities, etc.

Why Enter?

Winners of the Challenge will win no-strings-attached funding, as well as a chance to meet partners who can help take their solutions further whether through networking, partnership, or funding.


Who Should Apply

Innovators interested in supporting national defense efforts to enhance medical, chemical, biological, radiological, and nuclear capabilities and with the technical foundation to make a difference.


Submissions Closed


Submissions Open: February 5, 2024

Informational Webinar:
March 14, 2024 at 3:30pm ET

Submissions Close: March 28, 2024   
Notify Finalists:: Mid-April 2024   
Finalist Confirmation Due: Late-April 2024   

Pitch Event

TechConnect will invite finalists to pitch at Techconnect World Innovation Conference

Date: June 18, 1:30 - 4:30

Location: Gaylord National Convention Center and Hotel, National Harbor, MD


  • Center for Applied NanoBioscience and Medicine (ANBM) at The University of Arizona
  • Ceria Therapeutics
  • DxLab, Inc.
  • Linshom Medical
  • PrecNA LLC
  • Quanterix Corporation
  • ReliOx Corporation
  • SimWerx
  • SingleTimeMicroneedles
  • SPOC Proteomics
  • SynerGene Therapeutics, Inc.
  • Thylacine Biotherapeutics Inc
  • University of Maryland
  • Vaxess Technologies

Consortium Membership

Consortia relieve some of the contractual burdens typically placed on contractors working for federal clients, making it possible for nontraditional contractors to participate in technology development.

The MCDC Consortium accelerates the US Department of Defense's fielding of prototypes for medical countermeasures. It was formed in response to the government's expressed interest to support DOD medical pharmaceutical and diagnostics requirements, as related to enhancing mission effectiveness of military personnel. Learn more about MCDC Consortium here: https://www.medcbrn.org/


For submission questions, please contact Laura Murphree at laura@techconnect.org.
To Sponsor or Partner please contact Nick Kacsandi at nkacsandi@techconnectventures.com.

  Twitter     Linkedin  
Sponsors & Partners
SBIR/STTR Agency Partners